This study investigates the effectiveness and safety of an investigational treatment for people aged 12 and older with moderate-to-severe atopic dermatitis (AD). Participants must have had an inadequate response to previous biologic therapy or an oral JAK inhibitor. The study involves using a subcutaneous solution alongside topical corticosteroids.The purpose is …
This study investigates the effect of an investigational medication, an Anti-OX40L Monoclonal Antibody, in adults with moderate to severe atopic dermatitis. The study will compare the investigational medication to other treatment arms to assess its effectiveness.Participants will be randomly assigned to one of five study arms in a double-blind manner, …
This study investigates atopic dermatitis in adolescents and adults who begin or change systemic treatments.The study focuses on understanding the patient journey and evaluating the safety and outcomes of treatments for atopic dermatitis in real-world settings.Who can participate: Participants must be 12 years or older with a confirmed diagnosis of …
This study investigates the effects of atopic dermatitis (AD) on pregnancy outcomes. This observational study will compare the incidence of adverse pregnancy outcomes, such as miscarriage or stillbirth, and the prevalence of adverse infant outcomes, like major congenital malformations or being small for gestational age, in women with AD who …
